Zhang QZ - Search Results

1

PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.

Han QJ, Zhu YP, Sun J, Ding XY, Wang X, Zhang QZ. Han QJ, et al. Among authors: zhang qz. Front Pharmacol. 2024 Jul 5;15:1418560. doi: 10.3389/fphar.2024.1418560. eCollection 2024. Front Pharmacol. 2024. PMID: 39035989 Free PMC article.

2

Zhu YP, Deng HT, Wang X, Rahat MA, Sun S, Zhang QZ. Zhu YP, et al. Among authors: zhang qz. Front Pharmacol. 2023 Apr 11;14:1146468. doi: 10.3389/fphar.2023.1146468. eCollection 2023. Front Pharmacol. 2023. PMID: 37113755 Free PMC article.

3

TNFSF15 facilitates differentiation and polarization of macrophages toward M1 phenotype to inhibit tumor growth.

Zhao CC, Han QJ, Ying HY, Gu XX, Yang N, Li LY, Zhang QZ. Zhao CC, et al. Among authors: zhang qz. Oncoimmunology. 2022 Feb 1;11(1):2032918. doi: 10.1080/2162402X.2022.2032918. eCollection 2022. Oncoimmunology. 2022. PMID: 35127254 Free PMC article.

4

Editorial: Angiogenesis and tumor metastasis.

Zhang QZ, Zhu YP, Rahat MA, Kzhyshkowska J. Zhang QZ, et al. Front Oncol. 2023 Jan 17;12:1129736. doi: 10.3389/fonc.2022.1129736. eCollection 2022. Front Oncol. 2023. PMID: 36733363 Free PMC article. No abstract available.

5

A Supramolecular Strategy to Engineering a Non-photobleaching and Near-Infrared Absorbing Nano-J-Aggregate for Efficient Photothermal Therapy.

Su M, Han Q, Yan X, Liu Y, Luo P, Zhai W, Zhang Q, Li L, Li C. Su M, et al. ACS Nano. 2021 Mar 23;15(3):5032-5042. doi: 10.1021/acsnano.0c09993. Epub 2021 Feb 26. ACS Nano. 2021. PMID: 33635051

6

Matrix Metalloproteinase-9-Responsive Surface Charge-Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy.

Han QJ, Lan XT, Wen Y, Zhang CZ, Cleary M, Sayyed Y, Huang G, Tuo X, Yi L, Xi Z, Li LY, Zhang QZ. Han QJ, et al. Among authors: zhang cz, zhang qz. Adv Healthc Mater. 2021 May;10(9):e2002143. doi: 10.1002/adhm.202002143. Epub 2021 Mar 10. Adv Healthc Mater. 2021. PMID: 33694329

7

TNFSF15 facilitates the differentiation of CD11b⁺ myeloid cells into vascular pericytes in tumors.

Gu X, Zhu Y, Zhao C, Cao Y, Wang J, Zhang Q, Li L. Gu X, et al. Cancer Biol Med. 2023 Nov 2;20(11):869-84. doi: 10.20892/j.issn.2095-3941.2023.0245. Cancer Biol Med. 2023. PMID: 37921408 Free PMC article.

8

Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC.

Zhang Q, Liu X, Chen Z, Zhang S. Zhang Q, et al. Front Pharmacol. 2022 Aug 3;13:937531. doi: 10.3389/fphar.2022.937531. eCollection 2022. Front Pharmacol. 2022. PMID: 35991889 Free PMC article.

9

Branch-PCR constructed TP53 gene nanovector for potential cancer therapy.

Cheng L , Deng H , Ma D , Zhai B , Zhang Q , Li L , Xi Z . Cheng L , et al. Chem Commun (Camb). 2018 Aug 23;54(69):9687-9690. doi: 10.1039/c8cc05066j. Chem Commun (Camb). 2018. PMID: 30102306

10

Signaling in TNFSF15-mediated Suppression of VEGF Production in Endothelial Cells.

Zhao H, Zhang Q. Zhao H, et al. Methods Mol Biol. 2021;2248:1-18. doi: 10.1007/978-1-0716-1130-2_1. Methods Mol Biol. 2021. PMID: 33185864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters